Market Expansion AOM Infusion's recent expansion into the New York market and its nationwide pharmacy license position it well for targeted growth initiatives and partnerships in high-demand urban centers, presenting opportunities for sales of advanced infusion technologies and supportive healthcare solutions.

Strategic Collaborations The company's partnership with Kedrion Biopharma indicates openness to strategic collaborations and indicates a potential for further joint ventures in immunoglobulin and specialty therapy areas, suggesting avenues for joint product solutions and technology platforms.

Technological Investment AOM Infusion’s commitment to expanding therapy options and investing in innovative platforms signals an ongoing need for advanced healthcare IT solutions, secure digital documentation, and compliance tools to enhance patient care delivery and operational efficiency.

Financial Growth With revenues estimated between $25 million and $50 million and prior significant investment from Revelstoke Capital Partners, the company is likely seeking scalable infrastructure, process automation, and telehealth integration to support continued growth and increase market share.

Workforce Development As a specialized infusion provider with a skilled workforce of up to 200 employees, AOM Infusion presents opportunities for staffing solutions, operational tools, and employee engagement platforms to improve care quality and support expansion efforts.